&Partners’s Mesa Laboratories MLAB Stock Holding History

&Partners’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,664	Closed	-$251K	–	2160
2025 Q2	$251K	Sell	2,664 -50	-2%	-$5.49K	﹤0.01%	1712
2025 Q1	$324K	Buy	+2,714	New	+$370K	﹤0.01%	1369

Other funds holding MLAB

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

SCM

Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

KLP

Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return

&Partners's MLAB Position: Q3 2025 in Review

&Partners sold out of Mesa Laboratories (MLAB) in Q3 2025, closing a stake of 2,664 shares — an estimated $251K sold.

&Partners first reported a position in MLAB in Q1 2025 and held it in 2 quarters. The position peaked at $324K in Q1 2025. 141 funds tracked by Wall St. Rank hold MLAB as of Q3 2025.

&Partners reported no remaining Mesa Laboratories position as of Q3 2025 after selling out during the quarter.
&Partners sold 2,664 Mesa Laboratories shares in Q3 2025, an estimated $251K.
&Partners first reported a position in Mesa Laboratories in Q1 2025 and held it in 2 quarters.
&Partners's Mesa Laboratories position peaked at $324K in Q1 2025.
141 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2025.

Based on &Partners's 13F filing for Q3 2025, filed 14 Nov 2025.